Predictive Biomarkers for Immune-Related Endocrinopathies following Immune Checkpoint Inhibitors Treatment

SIMPLE SUMMARY: In the last decade, immune checkpoint inhibitors have been incorporated into the array of oncologic treatments used in daily practice, leading to the improved prognosis of many cancers. With their widespread use, clinicians are increasingly confronted with a new category of adverse e...

Descripción completa

Detalles Bibliográficos
Autores principales: Shalit, Almog, Sarantis, Panagiotis, Koustas, Evangelos, Trifylli, Eleni-Myrto, Matthaios, Dimitris, Karamouzis, Michalis V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856539/
https://www.ncbi.nlm.nih.gov/pubmed/36672324
http://dx.doi.org/10.3390/cancers15020375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856539/
https://www.ncbi.nlm.nih.gov/pubmed/36672324
http://dx.doi.org/10.3390/cancers15020375

Ejemplares similares